Ellington Management Group’s Pediatrix Medical MD Stock Holding History

Ellington Management Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-49,600	Closed	-$577K	–	270
2020 Q1	$577K	Buy	49,600 +28,557	+136%	+$589K	0.14%	221
2019 Q4	$585K	Buy	+21,043	New	+$528K	0.12%	141
2019 Q2	–	Sell	-48,160	Closed	-$1.31M	–	700
2019 Q1	$1.31M	Buy	48,160 +37,460	+350%	+$1.26M	0.24%	102
2018 Q4	$353K	Buy	+10,700	New	+$430K	0.11%	200
2017 Q3	–	Sell	-12,900	Closed	-$779K	–	756
2017 Q2	$779K	Buy	12,900 +1,800	+16%	+$107K	0.11%	134
2017 Q1	$770K	Buy	+11,100	New	+$771K	0.03%	163
2014 Q3	–	Sell	-8,300	Closed	-$483K	–	397
2014 Q2	$483K	Buy	+8,300	New	+$488K	0.23%	126
2013 Q3	–	Sell	-5,000	Closed	-$229K	–	895
2013 Q2	$229K	Buy	+5,000	New	+$224K	0.04%	623

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ellington Management Group's MD Position: Q2 2020 in Review

Ellington Management Group sold out of Pediatrix Medical (MD) in Q2 2020, closing a stake of 49,600 shares — an estimated $577K sold.

Ellington Management Group first reported a position in MD in Q2 2013 and held it in 8 quarters. The position peaked at $1.31M in Q1 2019. 215 funds tracked by Wall St. Rank hold MD as of Q2 2020.

Ellington Management Group reported no remaining Pediatrix Medical position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 49,600 Pediatrix Medical shares in Q2 2020, an estimated $577K.
Ellington Management Group first reported a position in Pediatrix Medical in Q2 2013 and held it in 8 quarters.
Ellington Management Group's Pediatrix Medical position peaked at $1.31M in Q1 2019.
215 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.